Status:
UNKNOWN
Inherited Risk Evaluation Tool (InheRET): Identifying Patients at Increased Risk for Hereditary Disease
Lead Sponsor:
InheRET, Inc
Collaborating Sponsors:
University of Michigan
Conditions:
Hereditary Cancer-Predisposing Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate the impact InheRET™, an online family history gathering and risk assessment reporting tool, has on facilitating National Comprehensive Cancer Network(NCCN) guideline compliant...
Detailed Description
This study will evaluate the impact InheRET™, an online family history gathering and risk assessment reporting tool, has on facilitating National Comprehensive Cancer Network(NCCN) guideline compliant...
Eligibility Criteria
Inclusion
- Primary Care sites:Adult patients with New and Health Maintenance Exam appointments at participating clinics
- Genetics sites: Adult patients with new referrals for genetic counseling
Exclusion
- Patients who were previously referred or who have an appointment for genetic counseling pending.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
2232 Patients enrolled
Trial Details
Trial ID
NCT04510896
Start Date
September 1 2020
End Date
August 31 2022
Last Update
July 30 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
InheRET, Inc.
Ann Arbor, Michigan, United States, 48109
2
Michigan Medicine
Ann Arbor, Michigan, United States, 48109
3
Hamilton Community Health Network - withdrew from study
Flint, Michigan, United States, 48505
4
Ascension St. Mary's Hospital - withdrew from study
Saginaw, Michigan, United States, 48604